tiprankstipranks
Trending News
More News >
SAB Biotherapeutics (SABS)
NASDAQ:SABS
US Market

SAB Biotherapeutics (SABS) Balance Sheet

Compare
315 Followers

SAB Biotherapeutics Balance Sheet

SAB Biotherapeutics's total assets for Q4 2025 were $172.81M, a decrease of -5.80% from the previous quarter. SABS total liabilities were $21.32M for the fiscal quarter, a 16.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Mar 25Dec 23Mar 23Dec 21
Total Assets
$ 172.81M$ 44.20M$ 83.94M$ 50.90M$ 81.14M
Total Liabilities
$ 21.32M$ 18.23M$ 26.64M$ 19.85M$ 42.59M
Total Equity Gross Minority
$ 151.49M$ 25.97M$ 57.30M$ 31.06M$ 38.55M
Other Metrics
Currency in USD

SAB Biotherapeutics Debt to Assets